Sophia Zoungas, School of Public Health and Preventive Medicine, Monash University, sophia.zoungas@monash.edu
The Australian National Diabetes Audit Longitudinal Register (ANDA–L) is a sub-study of the Australian National Diabetes Audit (ANDA) with its main focus to prospectively follow up the same cohort of patients over a 2 - 4 year period during the ANDA-AQCA (Australian Quality Clinical Audit) data collection. The data collected are clinical indicators known to have impact on the care of people with diabetes.
ANDA-L aims to:
- Measure and report on longitudinal trends in the characteristics, type of care and major clinical outcomes (including survival) of a cohort of patients with diabetes attending diabetes services nationwide, with all data aggregated at a national level
- Evaluate longitudinal associations between patient characteristics, quality of care and major clinical outcomes (including survival).
This allows participating centres to observe changes in clinical indicators for people with diabetes at both a group and individual level and offers a rich source of understanding of treatments, and clinical outcomes for people with diabetes. ANDA-L will provide longitudinal descriptive reporting to treating centres for quality management.
- Shared with clinicians
- Shared with hospital executive
- ANDA-L provides longitudinal descriptive reporting to treating participating centres for quality management.
Nil
Nil
New South Wales
- Greater Newcastle Sector Diabetes Service
- Liverpool Hospital
- Murrumbidgee Local Health District
Queensland
- Cairns Diabetes Centre
- Redland Hospital
Victoria
- Barwon Health - Geelong Hospital Campus
- Cobram District Health
- Dandenong Hospital
- Gateway Health-Wangaratta
- Gateway Health-Wodonga
- Goulburn Valley Health - Shepparton Campus
- Kyabram & District Health Services
- Monash Medical Centre - Clayton Campus
- Numurkah District Health Service
- Royal Melbourne Hospital - City Campus
- St Vincent's Public Hospital-Melbourne